The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
4-(2-Chlorophenyl)-N-(4-morpholinophenyl)-(2,4'-bithiazol)-2'-amine ID: ALA5273468
Max Phase: Preclinical
Molecular Formula: C22H19ClN4OS2
Molecular Weight: 455.01
Associated Items:
Names and Identifiers Canonical SMILES: Clc1ccccc1-c1csc(-c2csc(Nc3ccc(N4CCOCC4)cc3)n2)n1
Standard InChI: InChI=1S/C22H19ClN4OS2/c23-18-4-2-1-3-17(18)19-13-29-21(25-19)20-14-30-22(26-20)24-15-5-7-16(8-6-15)27-9-11-28-12-10-27/h1-8,13-14H,9-12H2,(H,24,26)
Standard InChI Key: GUGCCAUPCRJXRT-UHFFFAOYSA-N
Molfile:
RDKit 2D
30 34 0 0 0 0 0 0 0 0999 V2000
2.8631 1.5438 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1832 1.0766 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.5217 1.5978 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7939 2.3559 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
2.6227 2.3284 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.7443 1.3227 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.5937 0.5118 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.2420 0.4126 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
-0.5853 1.1408 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0197 1.7071 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.3821 1.3542 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.9653 0.7710 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.7520 -0.0255 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.3341 -0.6065 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.1309 -0.3929 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.3450 0.3994 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.7654 0.9855 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6077 1.1886 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2877 1.6555 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0294 1.3006 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0940 0.4782 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4185 0.0122 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6725 0.3629 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.7141 -0.9761 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-3.5007 -1.7727 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.0839 -2.3559 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.8805 -2.1424 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-5.0940 -1.3459 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.5108 -0.7627 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9582 -0.0493 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 2 0
3 4 1 0
1 5 2 0
5 4 1 0
3 6 1 0
7 6 2 0
7 8 1 0
8 9 1 0
10 9 2 0
6 10 1 0
9 11 1 0
11 12 1 0
13 12 2 0
14 13 1 0
15 14 2 0
16 15 1 0
17 16 2 0
12 17 1 0
1 18 1 0
19 18 2 0
20 19 1 0
21 20 2 0
22 21 1 0
23 22 2 0
18 23 1 0
15 24 1 0
25 24 1 0
26 25 1 0
27 26 1 0
28 27 1 0
29 28 1 0
24 29 1 0
23 30 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Topical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 455.01Molecular Weight (Monoisotopic): 454.0689AlogP: 6.17#Rotatable Bonds: 5Polar Surface Area: 50.28Molecular Species: NEUTRALHBA: 7HBD: 1#RO5 Violations: 1HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski): 1CX Acidic pKa: ┄CX Basic pKa: 2.44CX LogP: 6.35CX LogD: 6.35Aromatic Rings: 4Heavy Atoms: 30QED Weighted: 0.39Np Likeness Score: -2.09
References 1. Mao J, Wang D, Xu P, Wang Y, Zhang H, Wang S, Xu F, Wang J, Zhang F.. (2022) Structure-Based Drug Design and Synthesis of Novel N -Aryl-2,4-bithiazole-2-amine CYP1B1-Selective Inhibitors in Overcoming Taxol Resistance in A549 Cells., 65 (24.0): [PMID:36512763 ] [10.1021/acs.jmedchem.2c01306 ]